OncoSil Medical Limited OSL.AX Stock
OncoSil Medical Limited Price Chart
OncoSil Medical Limited OSL.AX Financial and Trading Overview
| OncoSil Medical Limited stock price | 0.0060 AUD |
| Previous Close | 0.01 AUD |
| Open | 0.01 AUD |
| Bid | 0.01 AUD x 0 |
| Ask | 0.01 AUD x 0 |
| Day's Range | 0.01 - 0.01 AUD |
| 52 Week Range | 0.009 - 0.07 AUD |
| Volume | 11.62M AUD |
| Avg. Volume | 4.9M AUD |
| Market Cap | 23.74M AUD |
| Beta (5Y Monthly) | 0.329118 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
OSL.AX Valuation Measures
| Enterprise Value | 6.4M AUD |
| Trailing P/E | N/A |
| Forward P/E | -1.2 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 18.783173 |
| Price/Book (mrq) | 2 |
| Enterprise Value/Revenue | 5.061 |
| Enterprise Value/EBITDA | -0.602 |
Trading Information
OncoSil Medical Limited Stock Price History
| Beta (5Y Monthly) | 0.329118 |
| 52-Week Change | -72.34% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.07 AUD |
| 52 Week Low | 0.009 AUD |
| 50-Day Moving Average | 0.01 AUD |
| 200-Day Moving Average | 0.03 AUD |
OSL.AX Share Statistics
| Avg. Volume (3 month) | 4.9M AUD |
| Avg. Daily Volume (10-Days) | 1.97M AUD |
| Shares Outstanding | 1.98B |
| Float | 832.52M |
| Short Ratio | N/A |
| % Held by Insiders | 11.57% |
| % Held by Institutions | 2.44% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -842.59% |
| Gross Margin | 11.51% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -85.40% |
| Return on Equity (ttm) | -177.26% |
Income Statement
| Revenue (ttm) | 1.26M AUD |
| Revenue Per Share (ttm) | 0.001 AUD |
| Quarterly Revenue Growth (yoy) | 32.89% |
| Gross Profit (ttm) | 90.91K AUD |
| EBITDA | -10625170 AUD |
| Net Income Avi to Common (ttm) | -10684989 AUD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.76M AUD |
| Total Cash Per Share (mrq) | 0.006 AUD |
| Total Debt (mrq) | 222.76K AUD |
| Total Debt/Equity (mrq) | 3.87 AUD |
| Current Ratio (mrq) | 4.09 |
| Book Value Per Share (mrq) | 0.006 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -10017541 AUD |
| Levered Free Cash Flow (ttm) | -6339216 AUD |
Profile of OncoSil Medical Limited
| Country | Australia |
| State | NSW |
| City | North Sydney |
| Address | 15 Blue Street |
| ZIP | 2060 |
| Phone | 61 2 9223 3344 |
| Website | https://www.oncosil.com.au |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced unresectable pancreatic cancer, in combination with gemcitabine-based chemotherapy. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in May 2013. OncoSil Medical Limited was incorporated in 2005 and is headquartered in North Sydney, Australia.
Q&A For OncoSil Medical Limited Stock
What is a current OSL.AX stock price?
OncoSil Medical Limited OSL.AX stock price today per share is 0.0060 AUD.
How to purchase OncoSil Medical Limited stock?
You can buy OSL.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for OncoSil Medical Limited?
The stock symbol or ticker of OncoSil Medical Limited is OSL.AX.
Which industry does the OncoSil Medical Limited company belong to?
The OncoSil Medical Limited industry is Medical Devices.
How many shares does OncoSil Medical Limited have in circulation?
The max supply of OncoSil Medical Limited shares is 2.26B.
What is OncoSil Medical Limited Price to Earnings Ratio (PE Ratio)?
OncoSil Medical Limited PE Ratio is now.
What was OncoSil Medical Limited earnings per share over the trailing 12 months (TTM)?
OncoSil Medical Limited EPS is -0.01 AUD over the trailing 12 months.
Which sector does the OncoSil Medical Limited company belong to?
The OncoSil Medical Limited sector is Healthcare.